Sherly Lawrensia

Sherly Lawrensia

Auto-generated profile, based on publicly available information

Sherly Lawrensia

Department of Internal Medicine, Hasan Sadikin General Hospital, Faculty of Medicine Universitas Padjadjaran West Java Indonesia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2022 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
NSNanny Natalia Muliani Soetedjo
Nanny Natalia Muliani Soetedjo
MIMaria Riastuti Iryaningrum
Maria Riastuti Iryaningrum
SLSherly Lawrensia
Sherly Lawrensia
HPHikmat Permana
Hikmat Permana

22 October 2020 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Open access
PDF file
SLSherly Lawrensia
Sherly Lawrensia
JHJoshua Henrina
Joshua Henrina
EWEllen Wijaya
Ellen Wijaya
LSLeonardo Paskah Suciadi
Leonardo Paskah Suciadi
ASAninka Saboe
Aninka Saboe
CCCharlotte Johanna Cool
Charlotte Johanna Cool
Initially, SARS-CoV-2 infection had been reported as a relatively mild case in children than in adults. Nevertheless, recent evidence found that a subset of children then developed a significant systemic inflammatory response that resembles atypical/typical Kawasaki’s disease (KD) and toxic shock syndrome. This novel clinical syndrome later identified as pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS). In contrast with KD, PIMS-TS appears to occur in children at an older age with a predominance of gastrointestinal symptoms, hemodynamic instability, and myocardial dysfunction. However, the exact pathomechanism remains to be understood. Nevertheless, the post-viral immunological reaction is postulated to be the underlying mechanistic underpinnings. The multifaceted nature of the PIMS-TS’ course underlines the need for early recognition and multispecialty care and management.

1 January 2021 in Thrombosis Update
Verified
Journal Article
Open access
JHJoshua Henrina
Joshua Henrina
IPIwan Cahyo Santosa Putra
Iwan Cahyo Santosa Putra
ICIrvan Cahyadi
Irvan Cahyadi
SLSherly Lawrensia
Sherly Lawrensia
HGHoo Felicia Hadi Gunawan
Hoo Felicia Hadi Gunawan
LSLeonardo Paskah Suciadi
Leonardo Paskah Suciadi
Venous thromboembolism is prevalent in hospitalized COVID-19 patients. Through systematic review and meta-analysis, we have investigated the differences in clinical characteristics and outcome of hospitalized COVID-19 patients with (+) and without (-) venous thromboembolism (VTE). 45 studies with a total of 8859 patients were included in the qualitative synthesis. Subsequently, 38 studies with a total of 7847 patients, were quantitatively analysed. There was no mortality difference between the VTE (-) and VTE (+) hospitalized COVID-19 patients (RR1.32 (0.97, 1.79); 0.07; I2 64%, p<0.001). Patients with VTE (+) were more likely to get admitted to the intensive care unit (RR1.77 (1.26, 2.50); p<0.001; I2 63%, p= 0.03) and mechanically ventilated (RR 2.35 (1.22, 4.53); p=0.01; I2 88%, p<0.001). Moreover, male gender (RR 1.19 (1.14,1.24), p<0.001; I2 0%, p=0.68), increased the risk of VTE. Regarding patients lab values’, VTE (+) was significantly associated with higher white blood cell, neutrophil count, D-Dimer, alanine aminotransferase (ALT), lactate dehydrogenase (LDH), and C-reactive protein (CRP), along with prolonged prothrombin time. On the contrary, VTE (+) was associated with lower albumin and neutrophil-lymphocyte ratio (NLR). This findings provide the initial framework for risk stratification of hospitalized COVID-19 patients with VTE.

27 April 2021 in Cureus
Verified
Journal Article
Open access
SLSherly Lawrensia
Sherly Lawrensia
JHJoshua Henrina
Joshua Henrina
ACAlius Cahyadi
Alius Cahyadi
CrossFit, a high-intensity interval training, keeps growing in trend and is one of the most favorable types of fitness, after wearable technology. However, an excessive workout is detrimental to the human body, particularly the muscle tissue. CrossFit is known to cause exercise-induced rhabdomyolysis, a concerning disease with potentially devastating consequences. Nevertheless, only a few case reports have described this disease, and this is the first case report of such disease in Indonesia to the best of our knowledge. A 27-year-old, previously healthy and active Indonesian male presented with dark urine and myalgia in lower extremities after 720 repetitions of squats three days before admission. His urinalysis showed +1 blood, 2-7 red blood cells/high power field (HPF), but negative protein. Laboratory results showed an increase in creatine phosphokinase (CPK) (54,250 U/L) and LDH (1,670 U/L) levels, consistent with exercise-induced rhabdomyolysis, and serum calcium of 1.87 mmol/L, with normal serum creatinine and BUN level. He was hospitalized for two days and was treated with intravenous hydration therapy. CrossFit-induced rhabdomyolysis is a potentially devastating disease. Apart from prompt diagnosis and treatment, further research regarding the safe number of repetitions for CrossFit training, particularly for lower extremities are needed. Predictors of CrossFit-induced rhabdomyolysis must be sought throughout, and participants’ awareness should be increased.

25 November 2025 in Chronic Diseases and Translational Medicine
Verified
Journal Article
Open access
YHYovita Hartantri
Yovita Hartantri
SLSherly Lawrensia
Sherly Lawrensia
SUSteven Yulius Usman
Steven Yulius Usman
NANenny Agustanti
Nenny Agustanti
RWRudi Wisaksana
Rudi Wisaksana
BABachti Alisjahbana
Bachti Alisjahbana
Introduction: Advances in HIV management have transformed HIV into a chronic condition, resulting in improved prognosis and increased survival among people living with HIV (PLWH). Traditional risk factors for metabolic dysfunction‐associated steatotic liver disease (MASLD)—including dyslipidemia—are prevalent in PLWH. This systematic review and meta‐analysis aim to synthesize current evidence on lipid profile disturbances as contributors to MASLD in PLWH. Methods: This systematic review and meta‐analysis were conducted according to Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines and registered in PROSPERO with registration number CRD420251054477. We searched seven databases to identify studies reporting the prevalence and characteristics of MASLD in PLWH. Meta‐analysis was conducted using Review Manager 5.4.1. Mean differences (MDs) were calculated using a random‐effects model. Risk of bias was assessed using the ROBINS‐E tool. Results: A total of 17 studies comprising 3933 HIV‐positive participants were included, among whom 1226 (37%) had MASLD. Male sex was significantly associated with MASLD (OR = 1.57; 95% CI: 1.13–2.17; p = 0.007). MASLD was significantly associated with higher body mass index (BMI) (MD = 3.23 kg/m²; p < 0.00001). Lipid profile analysis revealed that MASLD patients had higher total cholesterol (MD = 6.62 mg/dL; p = 0.01), low density lipoprotein (LDL) (MD = 3.83 mg/dL; p = 0.01), triglycerides (MD = 63.02 mg/dL; p < 0.00001), and lower high density lipoprotein (HDL) (MD = −3.73 mg/dL; p < 0.0001). Conclusion: This study demonstrates a significant difference in lipid profiles (higher total cholesterol, LDL, triglycerides, and lower HDL) among PLWH who develop MASLD, suggesting a potential metabolic signature associated with this comorbidity.